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Background: Cadmium (Cd) is a major environmental pollutant that causes multiple adverse health effects in
humans and animals. In this study, we investigated Cd-mediated toxic effects in rats during pregnancy and
endocrine intervention in the placenta.
Methods: We exposed pregnant rats to intraperitoneal Cd (CdCl2) at various doses (0, 0.25, and 0.5 mg/kg BW/day)
from days 5 to 19 of pregnancy and evaluated the maternal-placental-fetal parameters linked to preeclampsia.
We measured the corticosterone level in rat serum and placental tissue by sensitive ELISA and also analyzed the
expression of glucocorticoid synthesis enzymes in the placenta.
Results: Key features of preeclampsia (PE), including hypertension, proteinuria, glomerular endotheliosis, placental
abnormalities and small fetal size, appeared in pregnant rats after injection with 0.5 mg/kg BW/day Cd. The
placental corticosterone production and maternal and fetal plasma corticosterone levels were increased in rats
treated with 0.5 mg/kg BW/day Cd (P <0.01). The expression of 21-hydroxylase (CYP21) and 11beta-hydroxylase
(CYP11B1), enzymes essential for corticosteroid synthesis, were increased in Cd-exposed placenta (P <0.01).
11beta-hydroxysteroid dehydrogenase (11beta-HSD2), a dominant negative regulator of local glucocorticoid levels,
was decreased in Cd-exposed placenta (P <0.01).
Conclusions: Our study demonstrates for the first time that changes in placental glucocorticoid synthesis induced
by Cd exposure during pregnancy could contribute to preeclamptic conditions in rats.
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With increased industrial development, Cd exposure is
an increasingly important environmental hazard to both
humans and animals [1,2]. The general population is ex-
posed to Cd daily via the contamination of drinking
water and food and by the inhalation of cigarette smoke
[3]. Due to its long biological life and low excretion rate,
Cd can accumulate in various organs, mainly in the blood,
liver, kidney and reproductive systems. Pregnant women
are more vulnerable to Cd toxicity due to the greatly
increased absorption and retention of Cd caused by
nutritional deficiencies in protein and essential minerals* Correspondence: yphuangp@126.com
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unless otherwise stated.(particularly iron, calcium, zinc) during pregnancy [4]. Cd
has been implicated in the etiology of essential hyperten-
sion, but the relationship between Cd and preeclamptic
toxemia remains unclear.
Preeclampsia is a multisystem disorder characterized by
hypertension, proteinuria, edema and often fetal growth
restriction(FGR) [5,6]. The syndrome resolves after deliv-
ery, suggesting that the placenta is the principal contribu-
tor to the pathogenesis of preeclampsia [7]. The placenta
is also a primary target for Cd during pregnancy [8]. Cd
can accumulate in high concentrations in the placenta
with limited transfer to the fetus, although effects on fetal
birth size have been observed [9,10]. The placenta is
a temporarily important endocrine organ, producing
many hormones that affect the status of the pregnancy
and maternal physiology. Cd, similar to some othertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ruptor [11]. Several studies have reported that Cd directly
affects steroid synthesis in reproductive organs such as
the ovary and testes [12,13]. However, few studies have
been conducted to determine the endocrine effect of
Cd exposure during pregnancy [14]. Cd exposure dur-
ing pregnancy increases the levels of circulating cor-
ticosterone – the main active glucocorticoids (GC) in
rodents – in mothers and offspring, suggesting an in-
volvement of the GC system in some of the toxic ef-
fects induced by Cd [15]. Glucocorticoids are steroid
hormones and are classically thought to be secreted ex-
clusively by the adrenal glands. However, recent evidence
has shown that local corticosteroid synthesis may be trig-
gered in various other tissues during pathological condi-
tions and is therefore regulated by local processes in an
adrenal-independent manner [16]. High cortisol levels are
associated with hypertension and endothelial dysfunction,
features often observed in patients with PE [17]. This
paper presents a hypothesis suggesting the involvement of
Cd in the etiopathogenesis of preeclampsia based on the
endocrine intervention to placenta.
Methods
Experimental animals
All animal experiments were approved by the Institutional
Animal Care and Use Committee, Tongji Medical College,
Wuhan, China. The ethical approval date was December
2, 2012 and the reference number was IACUC [2012]340.
Female Sprague–Dawley rats (10 to 12-weeks old, 200-
240 g) were purchased from the Experimental Animal
Center of Tongji Medical College, Huazhong University
of Science and Technology. Animals were housed indi-
vidually in plastic cages with wood chips as bedding
under pathogen-free conditions in a controlled environ-
ment at 20–25°C and 12 hour light/dark cycles. Rats were
fed a standard laboratory diet and water ad libitum. The
rats were mated overnight with fertile male rats. The next
day was taken as day 1 of pregnancy if spermatozoa were
found in vaginal smears.
Maternal and fetal experiments
Experimental protocol
Pregnant rats were randomly divided into three groups:
the control group (n = 6), the 0.25 mg/kg Cd group (n = 7)
and the 0.5 mg/kg Cd group (n = 8). Cd (Sinopharm
Chemical Reagent Co. Ltd.) dissolved in sterile saline was
administered to the dams in each Cd group by intraperito-
neal injection from GD 5 to GD 19. Maternal weight was
monitored throughout the dosing period, and the dosing
volume was 2 ml/kg body weight. The control group re-
ceived only sterile saline. Six non-pregnant rats received
an intraperitoneal injection of 0.5 mg/kg Cd as non-
pregnant controls.Measurement of systolic blood pressure
Systolic blood pressures (SBP) were measured in con-
scious, restrained pregnant rats in the morning. An au-
tomated system with a photoelectric sensor linked to a
dual channel recorder (BP-98A, Softron, Japan), tail cuff
and sphygmomanometer was used to obtain indirect blood
pressure measurements. The measurements were obtained
at 4 different time points: before pregnancy and when the
animals were 1–4 days, 10–13 days, 19 days pregnant, re-
spectively. For the non-pregnant animals, comparable time
periods were utilized.
Determination of urinary albumin excretion
On days 3 and 19 of pregnancy, the rats were placed in
metabolic cages for 24-hour urine collection. To avoid
contaminating the collected urine, rats were restricted
from food; however, they were allowed free access to
water. To avoid adverse effects of fasting, rats were fed
in other cages for 30 min every 6 hours. Urine protein
concentrations were determined with a BCA protein assay
kit using bovine serum albumin as standard.
Specimen collection
On day 20 of pregnancy, rats were anaesthetized bet-
ween 9:00 a.m. and 10:00 a.m. to avoid hormonal circa-
dian interference. Maternal blood was collected by cardiac
puncture and put in polyethylene tubes pre-rinsed with
EDTA. Plasma was prepared by centrifugation for 10 min
at 3000 g at 4°C. After the rats were killed, pups were de-
livered by caesarean section. The plasma samples and the
remaining placentas were stored at −80°C until analysis.
Determination of cadmium concentrations
Cd in maternal and fetal blood and placenta tissue was
measured by inductively coupled plasma mass spectrom-
etry ICP-MS (ICP-MS; Agilent 7500 with a Cd program)
with a detection limit of 15 μg/L for blood and 0.03 μg/g
for solid samples.
Histology and immunohistochemistry
Small parts of the kidneys and placentas harvested from
each pregnant rat were randomly selected and fixed
horizontally in 10% neutral-buffered formaldehyde solu-
tion. After dehydration, the samples were embedded in
paraffin, and 4-μm sections were cut by a microtome
and collected for routine H&E or immunohistochemical
examination. Sections were then incubated overnight
with primary goat anti-CYP11B Abs (1:300 Santa Cruz)
or rabbit anti-11β-HSD2 Abs (1:300 Biosynthesis
Biotechnology) at 4°C. Immunoreactivity was detected
using biotinylated secondary antibodies, and the avidin-
biotin complex was visualized using DAB (DAB peroxidase
substrate kit, Vector Laboratories). Counterstaining was
performed with hematoxylin to enhance nuclear detection.
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Enzyme-linked Immunosorbent assay
The concentration of corticosterone was determined
using a corticosterone ELISA kit from Cayman Chemical
according to the manufacturer’s instructions. The results
are expressed in ng/ml of plasma. For placental cortico-
sterone concentrations, frozen placentas stored at − 80°C
were thawed, and 100 mg of tissue was homogenized in
enzyme immunoassay buffer containing 0.1 M phos-
phate solution with 0.1% BSA, 0.4 M NaCl and 1 mM
EDTA and centrifuged at 1500 g for 15 min at 4°C. The
results are expressed as pg/mg of tissue.
Reverse transcription-PCR analysis of mRNA expression
The placental tissues were homogenized with TRIzol
reagent (Invitrogen), and total RNA was extracted ac-
cording to the manufacturer’s instructions. A reverse
transcription-PCR (RT-PCR) procedure was used to deter-
mine the relative quantities of mRNA (One Step RT-PCR
kit, Qiagen). GAPDH was used as the internal control.
The primers for all genes tested are listed in Table 1.
Amplified cDNA was separated by electrophoresis on a
1.6% agarose gel and identified with Gold View.
Protein isolation and western blot
Protein was extracted from placental tissue using the
ProteoJET™ Mammalian Cell Lysis and Cytoplasmic Ex-
traction Kit. Protein concentrations were determined
using a BCA protein assay kit. We separated the pro-
teins (50 μg) on an 11.5% gel and transferred them to
PVDF membranes (Bio-Rad). Anti-CYP11B1 (1:500) andTable 1 Oligonucleotides sequences used for RT-PCR
Target mRNA Prime Sequence




CYP11A1 Forward 5′- CTGCCTGGGATGTGATTT −3′
Reverse 5′-GGAAGTGCGTGGTGTTTT −3′
3β-HSD Forward 5′- TCAAATCCATACCCATACAGC-3′






Reverse 5′-TGCTCAATGTAGTCTTCACC-3′11β-HSD2 (1:500) were applied. Bound antibody was
detected by enhanced chemiluminescence on an X-ray
film. We analyzed the relative densities of the bands with
Image J 1.47. The band densities were normalized to
GAPDH (glyceraldehyde-3- phosphate dehydrogenase).
Statistics
All statistical analyses were performed using SPSS 16.0
software. Numerical results are expressed as the mean ±
SEM of multiple experiments. We used a mixed-model
repeated-measures analysis to compare the characteris-
tics of pregnant rats exposed to different doses of Cd.
The means of the different groups were compared by a
one-way ANOVA followed by a Tukey multiple com-
parison test and by the Kruskal-Wallis (when the data
were not normally distributed). Differences were con-
sidered to be statistically significant when the P value
was < 0.05.
Results
Characteristics of pregnant mothers
The characteristics of rats subjected to different Cd
dose during pregnancy are described in Figure 1. Ma-
ternal daily weight gain through the dosing period
was significantly lower in the 0.5 mg/kg of Cd treat-
ment group compared to the control group from GD
8 to GD 20. In terms of maternal total weight gain,
the group that received 0.5 mg/kg Cd gained signifi-
cantly less weight compared to the other groups (P <0.05,
Figure 1A).
Hypertension is a defining feature of preeclampsia.
Figure 1B showed that exposure of pregnant rats to
0.5 mg/kg Cd resulted in a significant pregnancy-dependent
increase in systolic blood pressure compared with non-
pregnant animals at GD 19 (P <0.01). Systolic blood pres-
sures for pregnant rats exposed to 0.5 mg/kg of Cd were
significantly higher than the blood pressures of rats in the
control group (P <0.01) and the 0.25 mg/kg of Cd group
(P <0.01) at GD 19.
The 24-hr urinary albumin excretion, another defining
feature of preeclampsia, was measured in pregnant rats.
The results show that a pregnancy-dependent increase
in urinary albumin occurred after injection of 0.5 mg/kg
Cd in contrast to non-pregnant rats (P <0.01) that re-
ceived the same treatment, and an increase was not ob-
served in other pregnant groups. Proteinuria in the
0.5 mg/kg Cd group was significantly different from
both the control group and the 0.25 mg/kg Cd group
(P <0.01, Figure 1C).
Characteristics of fetuses
We also examined the outcomes from these pregnancies
(seen in Table 2). Prenatal Cd exposure did not sig-
nificantly affect placental weight or implantation size
Figure 1 SD rats develop preeclampsia-like symptoms in response to cadmium. Pregnant rats were given saline (in control group) or 0.25
or 0.5 mg/kg Cd intraperitoneally on GD 5 to GD 19. Maternal body weight, systolic blood pressure and 24-hour urinary protein excretion
are presented in (A), (B) and (C), respectively. All data are expressed as the mean ± SEM. *P < 0.05 compared with the control group and
non-pregnant rats.
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in rats from the 0.5 mg/kg Cd group compared with the
control group (P <0.05). The 0.5 mg/kg Cd dose re-
sulted in considerably more prenatal losses (due ei-
ther to resorption and/or stillbirth) (P <0.01). A 28%
reduction in fetal body weight and 30% reduction in
the litter size of viable fetuses were observed in the
0.5 mg/kg Cd rats compared with control rats (P <0.05).
The fetal weight:placental weight ratio and crown rump
length in 0.5 mg/kg Cd-treated rats decreased signifi-
cantly compared with control fetuses (P <0.05; P <0.001,







Control 0.51 ± 0.09 12.5 ± 2.3 0.17 ± 0.41
Cd2+0.25 0.48 ± 0.06 11.6 ± 1.4 0.57 ± 0.79
Cd2+0.5 0.46 ± 0.05 10.9 ± 1.8 2.25 ± 2.05*
Data are the mean ± SEM (n = 6–8 pregnant mice).
*P < 0.05 compared with the control group.
**P < 0.01 compared with the control group (one-way ANOVA followed by a Tukey
normally distributed).Morphological changes in the placenta , decidua and
kidney with preeclampsia
As showed in Figure 2, Cd treatment caused placental
thickening in the media of vessel walls and degeneration
and excessive perivillous fibrin deposition in the placen-
tal labyrinth. Additionally, vacuolization and swelling de-
cidua were found in the 0.5 mg/kg Cd-treated group but
were absent in the control group.
Kidneys from the 0.5 mg/kg Cd-treated group displayed
swelling of endothelia cells that appeared to reduce capil-
lary space (glomerular endotheliosis) and thickening









12.3 ± 2.6 3.53 ± 0.67 7.00 ± 0.94 3.62 ± 0.1
11.0 ± 1.9 3.14 ± 0.56 6.56 ± 0.83 3.17 ± 0.35*
8.6 ± 3.5 2.51 ± 0.61* 5.52 ± 1.33* 2.74 ± 0.36**
multiple comparison test or by the Kruskal-Wallis when the data were not
Figure 2 Hematoxylin-eosin stain for placental, decidua and kidney pathological analysis. Placenta, decidua and kidney specimens were
obtained from normal pregnancy rats and 0.5 mg/kg Cd-treated rats on day 20 of pregnancy. Left side photos are from the control group and
right side photos are from Cd-treated group. Hematoxylin-eosin staining was used for pathological analysis. (A) Representative images of the
placenta (original magnification X200). Black arrows indicated degeneration and excessive perivillous fibrin deposition in the placental labyrinth.
Blue arrows indicated leukocytes. (B) Representative images of the decidua (original magnification X400). Black arrows indicated vacuolization and
swelling decidua. (C) Representative images of the kidney (original magnification X400). Black arrows indicated glomerular endotheliosis. Blue
arrows indicated thickening of the media of renal vessel walls.
Table 3 Effect of cadmium treatment in rats during







control 142.1 ± 15.5 115.9 ± 5.1 79.7 ± 5.2
Cd2+0.5 231.1 ± 12.9* 168.9 ± 9.4* 143.4 ± 11.0*
Results are expressed as the mean ± S.D. Significant differences between
groups, Wilcoxon rank sum test for independent samples. *P < 0.01 compared
with the control group.
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were observed in the pregnant rat kidney. Accumulation
of inflammatory leukocytes was both observed in the pla-
centa and kidneys.
Cadmium concentrations
As expected, Cd levels in the placenta were significantly
higher for the 0.5 mg/kg Cd-treated group (2.81 ± 0.5 μg/g
dry weight) than the 0.25 mg/kg Cd-treated group (1.03 ±
0.3 μg/g dry weight, P <0.05). Cd was also detected in
the blood of mothers (30.6 ± 0.2 μg/L) in 0.5 mg/Kg Cd-
treated group. The Cd in the blood of fetuses whose mo-
thers were exposed to Cd, as well as in the blood of mother
in the control group was under the detectable level.
Circulating and local corticosterone concentrations
Because corticosterone is the main glucocorticoid in rats,
we determined corticosterone concentrations in plasma ofmothers and fetuses at GD 20 and also in placentas
collected after caesarean birth. Plasma corticosterone con-
centrations were significantly increased after prenatal ex-
posure to 0.5 mg/kg Cd compared to the control group in
both pregnant rats and their offspring (P <0.01, Table 3).
The concentration of corticosterone in the local placental
tissue was also increased in the 0.5 mg/kg Cd injection
group (P <0.01). These data indicate that PE-like features
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in the groups with high circulating and local cortico-
sterone levels. The minimum level of detection of the
assay was 150 pg/ml.
Corticosterone biosynthesis pathway
As outlined in Figure 3A, we observed that CYP11A1
was slightly increased in the 0.5 mg/kg Cd treatment
group (P <0.05). The levels of CYP21 and CYP11B1
mRNA expression in normal placenta tissue were below
detectable levels. In contrast, a low level of CYP21 and
CYP11B1 mRNA was observed in the placenta of the
0.5 mg/kg Cd treatment group (P <0.01). To investigate
whether the increased mRNA expression also resulted in
increased protein expression, we determined CYP11B1
protein expression by immunohistochemical staining
and Western blot. Our study revealed low levels and
sparsely distributed CYP11B primarily localized in pla-
cental labyrinthine trophoblasts. Weak but significantly
higher CYP11B1 protein expression was detected in the
placenta of the 0.5 mg/kg Cd treatment group (P <0.01).
We also compared the amount of mRNA of each ste-
roidogenic enzyme in the rat placenta with that in the
rat adrenal gland. The concentrations of CYP21 and
CYP11B1 in the placenta were much lower than those
in the adrenal gland (data not shown).
The direct demonstration of the presence of the whole
set of enzymes necessary for glucocorticoids production
in placenta supports the ability of the rat placenta toFigure 3 Expression of steroidogenic enzymes in placental tissue. The
in the 0.5 mg/kg Cd treatment group. The representative photographs for
that yielded similar results. GAPDH was used as the loading control. (A) Sim
Detection of steroidogenic enzyme gene expression by RT-PCR in rat adren
enzymes in the rat placenta. *P < 0.05 compared with the control group. (B
in the labyrinth zone of rat placenta (original magnification X400). (C) Com
based on Western blot. *P < 0.01 compared with the control group.synthesize the local production of corticosteroids after
exposure to Cd.
Regulation of glucocorticoid activity by 11β-HSD in
the placenta
11-hydroxysteroid dehydrogenase (11β-HSD) is a domi-
nant regulator of local glucocorticoid levels. 11β-HSD1
generates active glucocorticoid through catalyzing the
conversion of 11-dehydrocorticosterone to corticosterone
and cortisone to cortisol. In contrast, placental 11β-HSD2
protects the fetus from the adverse effects of maternal glu-
cocorticoids by interconverting the active glucocorticoids
to their inactive metabolites. Surprisingly, when compared
with the control groups, the expression of 11β-HSD1
was not changed (P =0.14), whereas 11β-HSD2 was sig-
nificantly reduced in the placenta of Cd-treated rat at
both the mRNA and protein levels (P <0.01, Figure 4).
11β-HSD2 was mainly localized in the cytoplasm of the
labyrinthine and spongiotrophoblasts layers of the pla-
centa. The above data suggest that prenatal exposed to Cd
may induce the downregulation of 11β-HSD2, leading to
increased local glucocorticoid activity in the placenta.
Discussion
Previous studies have shown that hypertension was in-
duced by the intraperitoneal administration of 1 mg/kg/
day Cd for 15 days in non-pregnant rats [18,19]. Hy-
pothesizing that pregnant rats are more susceptible to
Cd toxicity, we exposed pregnant rats to relatively lowexpression of steroidogenic enzymes in placental tissue was detected
PCR or Western bolt were from one of three independent experiments
plified scheme of the rat glucocorticoids biosynthesis pathway.
al gland or placenta. Comparison of the expression of steroidogenic
) Immunohistochemical localization and expression of CYP11B enzymes
parison of the expression of CYP11B1 protein levels in the rat placenta
Figure 4 Regulation of glucocorticoid activity by 11β-HSD in the placenta. Downregulation of 11β-HSD2 (negative feedback enzyme) is
induced by Cd in the rat placenta. The representative photographs for PCR or Western blots were from one of three independent experiments
that yielded similar results. GAPDH was used as the loading control. (A) 11β-HSD1 and 11β-HSD2 mRNA levels were analyzed by RT-PCR in the rat
placenta. The expression of 11β-HSD1 and 11β-HSD2 mRNA was compared between the control group and the 0.5 mg/kg Cd treatment group.
*P < 0.01 compared with the control group. (B) Immunohistochemical staining of 11β-HSD2 protein in the labyrinth zone of placenta
(original magnification ×400). (C) The expression of 11β-HSD2 was analyzed by Western blot in the rat placenta. *P < 0.01 compared with
the control group.
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fetal parameters linked to preeclampsia. We demonstrated
that the hallmarks of preeclampsia, including acute ma-
ternal hypertension, hyperalbuminuria and IUGR, were
found in SD rats exposed to 0.5 mg/kg Cd during gesta-
tion (GD5-19). The typical changes in the maternal en-
dothelium in preeclampsia ere also observed in the rat
kidney after Cd treatment. The reduction in fetal weight
independent of placental weight in the 0.5 mg/kg Cd-
treated group has been postulated to result from an
abnormal placenta with impaired function and reduced
perfusion after fetal and/or placental exposure to Cd.
To explore the biochemistry underlying these physio-
logical changes, we used a very sensitive ELISA to detect
placental corticosterone. A marked increase in the con-
centration of placental corticosterone was observed in
rats treated with Cd. High corticosteroid concentrations
in extra-adrenal organs, sometimes much higher than
circulating concentrations, is evidence of local synthesis.
Despite the presence of 11-HSD, which is involved in
the upregulation of glucocorticoids in the placenta [20],
in our opinion it is also possible that a classical gluco-
corticoid biosynthesis pathway may be involved in these
processes. To date, few studies have examined the levels
of steroidogenic enzymes necessary for de novo synthesis
of corticosterone from cholesterol in the placenta [21].
The placenta utilizes maternal cholesterol as the initial
substrate to produce progesterone for the duration of
the pregnancy, and most of the produced progesterone
enters the maternal circulation [22]. Progesterone is also
a source of corticosteroid precursors. StAR is a protein
involved in the shuttling of cholesterol to the innermitochondrial membrane for enzymatic conversion. In
the placenta, cytochrome P450scc (CYP11A1) is the most
important and rate-limiting enzyme for the conversion of
cholesterol to pregnenolone [23]. 21-hydroxylase (CYP21)
and 11-beta-hydroxylase (CYP11B1) are required for cor-
ticosterone synthesis; they convert progesterone to cor-
ticosterone. According to our research, although there
was a slight increase in CYP11A1 mRNA, there was no
significant change in StAR and 3β-HSD mRNA after ex-
posure to Cd, indicating that 0.5 mg/kg Cd does not affect
placental gonadal steroidogenesis, especially progesterone
biosynthesis, in rats. CYP11B1 is required for the final
steps of glucocorticoids synthesis and is followed by the
activity of the CYP21 enzyme [24]. In our studies, the ex-
pression of CYP21A and CYP11B1 mRNA in normal rat
placenta tissue was too low to be detected consistently
and reproducibly, so the ability of normal placenta to pro-
duce corticosterone is very limited, which is in agreement
with the data reported by Sybulski [25]. After Cd injection,
CYP21A and CYP11B1 mRNAs in the placenta increased,
although the levels were still lower levels than those in the
adrenal gland. However, it should be remembered that be-
cause the placenta is much larger than the adrenal gland,
the total mRNA for glucocorticoid-synthesizing enzymes
in the entire placenta could not be underestimated. The
enzyme CYP11B1 was detected rather easily using immu-
nohistochemistry or western blot, suggesting that the pro-
tein is stable in the placenta. The expression of either of
these enzymes would enable the placenta to use circulat-
ing steroid precursors or local progesterone to increase
the local levels of active glucocorticoids, which influence
placental structure and function. The mechanisms by
Wang et al. Reproductive Biology and Endocrinology 2014, 12:77 Page 8 of 9
http://www.rbej.com/content/12/1/77which Cd affect gene expression may include mimicry
of the effects of Ca2+ at low concentrations of Cd2+
due to the similarity of the ionic radii [26], resulting
in stimulation of the steroidogenic pathway and synthesis
of corticosteroids. We proved that local corticosteroid
synthesis may be activated under pathological conditions
in placenta.
In normotensive pregnancy, glucocorticoids are inacti-
vated but are frequently present after downregulation of
11β-HSD2 by adverse prenatal experiences [27,28]. We
found that the placenta of rats with preeclampsia during
pregnancy is characterized by decreased 11β-HSD2 with
unchanged 11β-HSD1. Cd can directly inhibit the tran-
scription of the 11β-HSD2 gene [29]. This local increase
in the utility of glucocorticoids is very important because
it allows increased ability of active glucocorticoids to
cross the placenta barrier, which accounts for the ele-
vated fetal corticosterone concentrations associated with
low birth weight.
In conclusion, this study demonstrates for the first
time that the placenta may be an extra-adrenal site of
glucocorticoid synthesis due to prenatal Cd exposure in
rats. Most of the reviewed research findings suggest that
in micromolar concentrations Cd causes upregulation of
the mediators and markers of inflammation and appears
to have proinflammatory properties [30]. Increasing the
local concentration of glucocorticoids is a protective me-
chanism to control the deleterious effects of excessive
production of inflammatory mediators. Although we feel
that the present results are encouraging, further studies
are needed to elucidate the clinical implications of extra-
adrenal corticosteroidogenesis in the preeclamptic pla-
centas of Cd-exposed pregnant rats.
Conclusions
We found that prenatal exposure to a relatively low con-
centration cadmium will develop many of the phenotypic
characteristics of human preeclampsia, including hyper-
tension, proteinuria,and fetal growth restriction (FGR) in
rat. We present the first evidence that cadmium exposure
during pregnancy induces local synthesized glucocorticoid
in placenta and contributes to preeclampsia in rat. This is
a potentially important hypothesis for experimental inves-
tigation, given the relevance of human exposure to Cd
and its hazard to pregnancy.
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